These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Adrenocortical suppression following treatment with beclomethasone and budesonide. Prahl P Clin Exp Allergy; 1991 Jan; 21(1):145-6. PubMed ID: 2021872 [TBL] [Abstract][Full Text] [Related]
23. Urine cortisol excretion in children treated with high doses of inhaled corticosteroids: a comparison of budesonide and beclomethasone. Pedersen S; Fuglsang G Eur Respir J; 1988 May; 1(5):433-5. PubMed ID: 3169214 [TBL] [Abstract][Full Text] [Related]
24. Effects of high doses of inhaled corticosteroids on adrenal function in children with severe persistent asthma. Ninan TK; Reid IW; Carter PE; Smail PJ; Russell G Thorax; 1993 Jun; 48(6):599-602. PubMed ID: 8346487 [TBL] [Abstract][Full Text] [Related]
25. A clinical comparison of intranasal budesonide with beclomethasone dipropionate for perennial non-allergic rhinitis: a 12 month study. Synnerstad B; Lindqvist N Br J Clin Pract; 1996; 50(7):363-6. PubMed ID: 9015907 [TBL] [Abstract][Full Text] [Related]
26. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects. Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918 [TBL] [Abstract][Full Text] [Related]
27. Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man. Johansson SA; Andersson KE; Brattsand R; Gruvstad E; Hedner P Eur J Respir Dis Suppl; 1982; 122():74-82. PubMed ID: 6958496 [TBL] [Abstract][Full Text] [Related]
28. Clinical efficacy of budesonide Turbuhaler compared with that of beclomethasone dipropionate pMDI with volumatic spacer. A 2-year randomized study in 102 asthma patients. Selroos O; Backman R; Forsén KO; Löfroos AB; Niemistö M; Pietinalho A; Riska H Allergy; 1994 Dec; 49(10):833-6. PubMed ID: 7709992 [TBL] [Abstract][Full Text] [Related]
29. High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society. Boe J; Bakke P; Rødølen T; Skovlund E; Gulsvik A Eur Respir J; 1994 Dec; 7(12):2179-84. PubMed ID: 7713201 [TBL] [Abstract][Full Text] [Related]
30. Skin bruising in asthmatic subjects treated with high doses of inhaled steroids: frequency and association with adrenal function. Roy A; Leblanc C; Paquette L; Ghezzo H; Côté J; Cartíer A; Malo JL Eur Respir J; 1996 Feb; 9(2):226-31. PubMed ID: 8777956 [TBL] [Abstract][Full Text] [Related]
31. Influence of high dose inhaled steroids on hypothalamo-pituitary-adrenal axis function in Japanese patients with asthma: a comparison over the course of time. Hasegawa T; Ishihara K; Fujii H; Hajiro T; Watanabe I; Nishimura T; Okazaki M; Katakami N; Umeda B Intern Med; 1996 May; 35(5):362-6. PubMed ID: 8797047 [TBL] [Abstract][Full Text] [Related]
32. An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers. Grahnén A; Eckernäs SA; Brundin RM; Ling-Andersson A Br J Clin Pharmacol; 1994 Dec; 38(6):521-5. PubMed ID: 7888290 [TBL] [Abstract][Full Text] [Related]
33. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients. Ringdal N; Lundbäck B; Alton M; Rak S; Eivindson A; Bratten G; Kjaersgaard P Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712 [TBL] [Abstract][Full Text] [Related]
34. No hypothalamic-pituitary-adrenal function effect with beclomethasone dipropionate nasal aerosol, based on 24-hour serum cortisol in pediatric allergic rhinitis. Hampel FC; Nayak NA; Segall N; Small CJ; Li J; Tantry SK Ann Allergy Asthma Immunol; 2015 Aug; 115(2):137-42. PubMed ID: 26250771 [TBL] [Abstract][Full Text] [Related]
35. Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids? Brown PH; Blundell G; Greening AP; Crompton GK Thorax; 1990 Oct; 45(10):736-9. PubMed ID: 2247863 [TBL] [Abstract][Full Text] [Related]
36. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Skoner DP; Rachelefsky GS; Meltzer EO; Chervinsky P; Morris RM; Seltzer JM; Storms WW; Wood RA Pediatrics; 2000 Feb; 105(2):E23. PubMed ID: 10654983 [TBL] [Abstract][Full Text] [Related]
37. Once-daily treatment with beclomethasone dipropionate nasal aerosol does not affect hypothalamic-pituitary-adrenal axis function. Ratner PH; Miller SD; Hampel FC; Melchior A; Dunbar SA; Tantry SK Ann Allergy Asthma Immunol; 2012 Nov; 109(5):336-41. PubMed ID: 23062389 [TBL] [Abstract][Full Text] [Related]
38. [Beclomethasone dipropionate, budesonide and flunisolide in the treatment of bronchial asthma (a review of the literature and the authors' own research)]. Kakhnovskiĭ IM; Solomatin AS Ter Arkh; 1995; 67(3):34-8. PubMed ID: 7770801 [TBL] [Abstract][Full Text] [Related]
39. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children. Clark DJ; Clark RA; Lipworth BJ Thorax; 1996 Sep; 51(9):941-3. PubMed ID: 8984708 [TBL] [Abstract][Full Text] [Related]
40. Dose of inhaled budesonide required to produce clinical suppression of plasma cortisol. Gordon AC; McDonald CF; Thomson SA; Frame MH; Pottage A; Crompton GK Eur J Respir Dis; 1987 Jul; 71(1):10-4. PubMed ID: 3653299 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]